CD8A and hepatocellular carcinoma: Comparison of CD4+T, CD8+T, CD4+/CD8+T and NK cell proportions in the peripheral blood of HCC patients before GSMs-TACE and at 1 to 2 weeks, 3 to 5 weeks after GSMs-TACE.